Arterial remodelling in Fabry disease

被引:38
作者
Boutouyrie, P
Laurent, S
Laloux, B
Lidove, O
Grunfeld, JP
Germain, DP
机构
[1] Hop Europeen Georges Pompidou, Dept Pharmacol, Paris, France
[2] Hop Europeen Georges Pompidou, INSERM, EMI 107, Paris, France
[3] Hop Necker Enfants Malad, Dept Nephrol, Paris, France
[4] Hop Europeen Georges Pompidou, Dept Genet, Paris, France
关键词
arterial stiffness; Fabry disease; intima-media thickness; remodelling; ultrasound;
D O I
10.1080/080352502762457950
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim: The enzymatic defect in Fabry disease results in the slow systemic deposition of uncleaved glycosphingolipids in the lysosomes of vascular endothelium and smooth muscle cells, leading to ischaemic strokes, cardiomyopathy and renal failure. Whereas it is known that Fabry disease affects small blood vessels, little is known about its effects oil peripheral large arteries. We therefore set out to compare parameters of arterial wall structure and function in a cohort of patients with Fabry disease and an age-matched control group. Methods: Large artery phenotype was non-invasively investigated in 21 hemizygous patients with Fabry disease and 24 age-matched male controls. Common carotid and radial artery diameter, intima-media thickness (IMT) and distensibility were determined with high-definition echotracking systems and aplanation tonometry. Results: Patients with Fabry disease had a significant twofold increase in radial artery IMT and distensibility, independent of body surface area, age and mean blood pressure. In both groups, older age at the time of examination was significantly associated with larger radial artery IMT. The relationship between age and radial IMT was 2.3-fold higher in patients with Fabry disease than in controls (p < 0.01). Carotid IMT was mildly but significantly increased in patients with Fabry disease (+18%), whereas distensibility was unchanged. Conclusion: This study presents evidence of a major increase in arterial wall thickness and distensibility, measurable at the site of a medium-sized artery, in a cohort of patients with classic Fabry disease.
引用
收藏
页码:62 / 66
页数:5
相关论文
共 27 条
[1]   Enhanced endothelium-dependent vasodilation in Fabry disease [J].
Altarescu, G ;
Moore, DF ;
Pursley, R ;
Campia, U ;
Goldstein, S ;
Bryant, M ;
Panza, JA ;
Schiffmann, R .
STROKE, 2001, 32 (07) :1559-1562
[2]   Association between local pulse pressure, mean blood pressure, and large-artery remodeling [J].
Boutouyrie, P ;
Bussy, C ;
Lacolley, P ;
Girerd, X ;
Laloux, B ;
Laurent, S .
CIRCULATION, 1999, 100 (13) :1387-1393
[3]   Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment [J].
Boutouyrie, P ;
Bussy, C ;
Hayoz, D ;
Hengstler, J ;
Dartois, N ;
Laloux, B ;
Brunner, H ;
Laurent, S .
CIRCULATION, 2000, 101 (22) :2601-2606
[4]   Non-invasive evaluation of arterial involvement in patients affected with Fabry disease [J].
Boutouyrie, P ;
Laurent, S ;
Laloux, B ;
Lidove, O ;
Grunfeld, JP ;
Germain, DP .
JOURNAL OF MEDICAL GENETICS, 2001, 38 (09) :629-631
[5]   ENZYMATIC DEFECT IN FABRYS DISEASE - CERAMIDETRIHEXOSIDASE DEFICIENCY [J].
BRADY, RO ;
GAL, AE ;
BRADLEY, RM ;
MARTENSS.E ;
WARSHAW, AL ;
LASTER, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (21) :1163-&
[6]   Clinical features of and recent advances in therapy for Fabry disease [J].
Brady, RO ;
Schiffmann, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (21) :2771-2775
[7]  
DeGraba T, 2000, ANN NEUROL, V47, P229, DOI 10.1002/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO
[8]  
2-T
[9]   Endothelial markers and homocysteine in patients with classic Fabry disease [J].
Demuth, K ;
Germain, DP .
ACTA PAEDIATRICA, 2002, 91 :57-61
[10]  
Desnick R.J., 1995, The Metabolic and Molecular Bases of Inherited Disease, P2741